| 1. | Post - marketing aderse eents : additional aderse eents reported from worldwide marketing experience with rabeprazole sodium are : , coma and hyperammonemia , jaundice , rhabdomyolysis , disorientation and delirium , anaphylaxis , angioedema , bullous and other drug eruptions of the skin , interstitial pneumonia , interstitial nephritis , tsh eleations
上市后不良反应：来自世界市场上有关雷贝拉唑的其他副反映：突然死亡、昏迷和高血氨，黄疸，横纹肌溶解、定向力障碍和谵妄，过敏反应，血管性水肿，大疱和皮肤表面的药物性出芽，间质性肺炎，间质性肾炎和tsh增加。 |
